Engineering CAR-T Cells for Improved Function Against Solid Tumors-Reference-Cited by-同舟云学术

Engineering CAR-T Cells for Improved Function Against Solid Tumors

Published:2018-10-29 Issue: Volume:9 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Morgan Michael A.,Schambach Axel

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference110 articles.

1. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells;Appleman;J Immunol.,2002

2. Src-family kinases negatively regulate NFAT signaling in resting human T cells;Baer;PLoS ONE,2017

3. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3;Steffen;J Immunol.,1988

4. IFN-gamma production by CD8+ T cells depends on NFAT1 transcription factor and regulates Th differentiation;Teixeira;J Immunol.,2005

5. IL-17 induces monocyte migration in rheumatoid arthritis;Shahrara;J Immunol.,2009

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like receptor 4 signaling activation domains promote CAR T cell function against solid tumors;Molecular Therapy: Oncology;2024-06

2. CAR-T cells for cancer immunotherapy;Chinese Chemical Letters;2023-09

3. Co-infusion of CAR T cells with aAPCs expressing chemokines and costimulatory ligands enhances the anti-tumor efficacy in mice;Cancer Letters;2023-08

4. Clinical Trials of Cellular Therapies in Solid Tumors;Cancers;2023-07-19

5. Chimeric antigen receptor T-cell therapy for multiple myeloma;Frontiers in Immunology;2022-12-22